It's definitely possible, probably just a very poor ROI...

  1. 4,409 Posts.
    lightbulb Created with Sketch. 4564
    It's definitely possible, probably just a very poor ROI currently given the infancy of the program.

    Licensing RC220 (in Japan for example) validates our near term clinical opportunity without giving away too much of the upside.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.19
Change
0.060(5.31%)
Mkt cap ! $206.7M
Open High Low Value Volume
$1.15 $1.20 $1.14 $204.7K 175.6K

Buyers (Bids)

No. Vol. Price($)
1 20 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.20 8000 1
View Market Depth
Last trade - 15.50pm 17/06/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.